Introduction
Cervical cancer associated with Human papilomaviruses especially with High Risk (HR) HPV genotypes is one the most public health problems in developing countries such as Iran. Based on the data reported by WHO, the crude incidence and mortality rates of HPV related cervical cancer until 2010 in Iran are about 1.8 and 0.8 per 100,000 per year, respectively. HPVs 16(HR), 18(HR), 31(HR), 6(LR), 11(LR), 33(HR) are the most common HPV genotypes in Iranian women with and without cervical dysplasia (WHO 2010; Laudadido 2013; Shayanfar et al., 2013) . It is proposed that individual genetic and epigenetic characteristics accompanied with HPV infection in cervical cancer have important role as main risk factors in cancer progression (Szalmás and Kónya., 2009; Wentzensen et al., 2009; Mohiuddin et al., 2013; Wang ., 2014 (Yang et al., 2009; Eijsink et al., 2011; Eijsink et al., 2012; Limpaiboon., 2012; Al-Shabanah et al., 2014; Ma et al., 2014) . Hence, we assessed the DNA methylation status of C13orf18 and C1orf166 genes as novel potential candidate diagnostic biomarkers in Iranian female population suffering cervical malignancies.
Materials and Methods

Clinical specimens
From March 2012 to April 2013, a total of 112 samples (48 Liquid Based Cytology and 64 Archival Formalinwomen with known cervical cancer and precancerous lesions admitted to Tehran Women Central hospital, Imam Khomeini Hospital and for each patient and clinical data were entered. The ethical considerations of the study were approved and a consent from was signed by each patient. Then Liquid Based Cytology (LBC) preservatives and FFPE blocks were transported to molecular biology department in health reference laboratory of ministry of health and medical
Extraction of HPV DNA and HPV genotyping
Viral DNA from LBC preservatives and tissue blocks was extracted using the QIAamp DNA Mini kit and QIAamp DNA FFPE Tissue kit (Qiagen, Germany), according to the manufacturer's instructions. Human Papillomavirus genotyping was performed by In-House Multiplex Real Time PCR developed and designed in our laboratory. The assay has been validated according to determined requirements for assessing the reliability for test (precision, trueness, detection limit, cross reactions HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 (High Risk) . ® , Germany), according to manufacturer's protocol. HeLa S3 (cervical cancer cell line) and health women pooled plasma are used amplifications were performed in a 20µl reaction volume containing 12.5µl 2X Premix Ex Taq (Probe qPCR) (TaKaRa, Japan), 10 pmol/µl each primers and probes (C13orf18: FP; 5'-TTTTTAGGGAAGTAAAGCGTCG-3', RP; 5'-ACGTAATACTA AACCCGAACGC-3' and TaqMan Probe; Yakima Yellow 5'-AGATGGAAG AAATT TTGGAGAT GC GCGTT-3' BHQ1) (C1orf166: FP; 5'-TGGCGAGTTAGTTATGGTT AGT G C-3', RV; 5'-TCTCCCCAA CCGAATATCGA-3' and TaqMan Probe; FAM 5'-TTATGGAGCGGTGG GTGGTCGTTTAG-3' BHQ1) (TIB MOLBIOL ® , Germany) (Yang et al., 2009; Eijsink et al., 2011; Eijsink et al., 2012) , and 5-6µl DNA extracted. These reaction following conditions: 95ºC; 90s for initial enzyme activation, for 50 cycles 95ºC; 5s,
Statistical analysis
of C13orf18 and c1orf166 genes and existence of Human Papillomaviruses, an using SPSS software version 18.5.
Results
Human Papillomviruses were detected in 105 of 112 (93.7%) LBC and Archival FFPE tissue specimens by In-House Multiplex Real Time PCR method. Overall, among the HPV genotypes, HPV18(69/61.6%), HPV16 (48/42.9%), HPV58(18/16.1%), HPV68(16/14.3%), HPV31(15/13.45), HPV52(15/13.45), HPV59(14/12.5%), HPV11(13/11.6%), HPV35(12/10.7%), HPV56(11/9.8%), HPV6(9/8%), HPV39(6/5.4%), HPV45(4/3.6%), HPV33(3/2.7%), HPV51(2/1.8%) and HPV negative (7/6.3%) were dominant genotypes in women with cervical dysplasia, respectively. Among samples with the HPV mix genotypes, HPV 16, 18 [13/105 (12.4%)] were the prevalent combination genotypes. The age range of women was 23-90 years and the mean age (SD) was 42.73 (±11.36) years old. HPV was detected in 68 (64.8 %) of the population study in ages between 31-50 years old. The frequency rates of DNA Methylation for C13orf18 and C1orf166 genes were 65 (58%) vs the existence of HPV genotypes infections and C13orf18 and C1orf166 DNA genes Table 1 and Figure 1 .
Discussion
Cervical carcinoma as a social problem with high morbidity and mortality in the worldwide is discussed. Insomuch, human papillomaviruses genotypes are considered as the main cause of malignancies particulary cervical cancer. Epigenetic and polymorphisms patterns as diagnostic biomarker and HPV genotypes detection can be used for determining appropriate treatment strategy for early stages of cervical cancer and increase survival in cervical malignancies (Nunobiki et al., 2011; Hwang and Shroyer 2012; Wang 2014 ). Therefore, the extensive studies have been done on the methylation analysis of various genes in different societies (Yang et al., 2009; Eijsink et al., 2011; Snellenberg et al., 2012; Sun et al., 2012; Banzai et al., 2013; Lan et al., 2013; AlShabanah et al., 2014; Ma et al., 2014) . Functional and MethyLight analysis of these genes shown that C13ORF18 gene might represents cervical cancer suppressive activities upon re-expression and C1ORF166, now known ligase that regulates the organelle's dynamics and NF-kB signaling. It is possible that these genes have functional role during cervical tumor development and progression (Li et al., 2008; Yang et al., 2009; Huisman et al., 2013) . The distribution of HPV 16 and HPV 18 along with other high risk HPV genotypes in this study is similar to other surveys (Clifford et al., 2005; Lee et al., 2011; Kasamatsu et al., 2012; Manjari and Sweta., 2012; Hamzi Abdul Raub et al., 2013; Turki et al., 2013; Wang et al., 2013; Othman and Othman., 2014) . Although the case studies have been conducted on methylation status of C13ORF18 and C1orf166 genes (Yang et al., 2009; Eijsink et al., 2011; Eijsink et al., 2012) . Likely, the methylated genes could be considered as proper diagnostic biomarkers in cervical cancer mid HPVs (Dueñas-González et al., 2005; Szalmás et al., 2009; Wentzensen et al., 2009; Nogueira da Costa and Herceg., 2012) . However, they were detected of DNA methylated genes for C13orf18; 65 (58%) and C1orf166; 45 (40%) in this research, but we did not found dysplasia and HPV genotypes previously found positive (p>0.05). Therefore, introducing these methylated genes as prognostic biomarkers of cervical cancer needs further studies with genetic patterns variation and various designs and acceptable number of clinical specimens.
In Conclusions, Obviously increased cervical cancer and precancerous lesions with HPV genotypes infection were seen in different regions of world, hence, further investigations should be emphasized for detection and development of molecular diagnostic biomarkers in cancers. More investigations on CpG methylation regions in different countries with more clinical samples biomarkers and treatment procedures in cancers. 
